Curved Soft-Picks on Plaque Accumulation on Patients With Gingivitis

Effect of Curved Design Soft-Picks on Plaque Accumulation on Patients With Signs of Gingivitis

The aim of this study is to evaluate the efficacy of a new interdental cleaning device (Soft-Picks Advanced), as compared to a leading brand floss; and, how ease of use can promote the establishment of a hygienic routine of cleaning interproximal spaces.

Study Overview

• Status: Completed
• Conditions: Gingivitis
• Intervention / Treatment: Device: Soft-Picks Advanced; Device: Floss

Detailed Description

The Soft-Picks Advanced has a new curved design allowing a user to easily access to difficult interdental sites, such as spaces between premolars and molars. This study is a single center with parallel design, single blinded, which will randomize eligible subjects into two treatment groups.

• Study Type: Interventional
• Enrollment (Actual): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • North Carolina
    • Chapel Hill, North Carolina, United States, 27599-7450
      • Department of Periodontology UNC School of Dentistry

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Be willing and physically able to carry out all study procedures and be available at all times required for participation
• Be able to fully understand and comply with the written and verbal instructions provided
• Provide written Informed Consent
• Be age 18 - 70 years
• Agree to return study materials at the required visit(s)
• Have a minimum of 20 'scorable' teeth (excluding 3rd molars)
• Have more than or equal 10% and less than or equal to 50% Bleeding on Probing (BOP) sites
• Have all Pocket Depth (PD) less than or equal to 4mm
• Have at least 12 qualifying, interproximal sites (6 per side) with closed contacts, without crown or restorations. (See section 5.1.1 'Teeth Selection')
• Be a regular manual toothbrush user for at least 2 months.
• Be a non-smoker for at least 2 years.
• Be willing to abstain from use of chewing gum and consumption of apples, carrots or other hard crunchy foods or thick skinned fruits for 3-6 hours before each visit.
• Be willing to comply with 12-18 hours of no oral hygiene practices

Exclusion Criteria:

• Medical or Dental condition that would be unduly affected by participation in this study, per Investigator Discretion
• Pregnant or nursing, per urine based pregnancy test
• A medical condition requiring antibiotic pre-medication prior to dental appointments
• Diagnosis of Xerostomia
• Any oral or extra oral piercing that interferes with the ability to perform study procedures and/or clinical assessments in the mouth
• Currently undergoing or requiring dental/periodontal treatment, or having had periodontal treatment in the six months preceding the study, where the subject's study participation could present an undue safety risk or obscure the evaluation of study endpoints, per Investigator /Examiner discretion
• Oral surgery within the last 2 months
• A known allergy or sensitivity to products planned for use in this study
• Unwillingness to abstain from all other oral hygiene products other than those prescribed for the duration of the study
• Participation in an oral care study within the previous 90 days
• Are a dental student or dental professional
• Uncontrolled Diabetes
• Current use of antibiotic medications or use within 4 weeks of enrollment
• Presence of heavy deposits of calculus, either supragingival and/or subgingival, per Investigator/Examiner discretion
• Extensive crown or bridge work, rampant decay or excessive gingival recession, per Investigator/Examiner discretion
• Presence of orthodontic bands interfering with efficacy outcome(s) per Investigator/Examiner discretion
• Current use of professionally dispensed bleaching products or use within one month of screening.
• Be an employee, spouse or a relative of an employee of the clinical research site, or a dental products manufacturing, research or marketing firm.
• Chronic treatment with any medication known to affect periodontal status within one month of the screening examination (daily use of 81 mg Aspirin is not exclusionary)
• Have any tooth sites with: > 5mm PD or attachment loss > 3mm, excluding 3rd molars

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Soft-Picks Advanced; Device: Curved Soft-Picks	Device: Soft-Picks Advanced; Soft-picks Advanced will be used once a day to clean interdental sites at home.
Active Comparator: Floss; Device: Waxed tape floss	Device: Floss; Floss will be used once a day to clean interdental sites at home.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Interproximal Plaque by Modification of the Quigley-Hein Plaque Index at 14 Days	Plaque scores shall be visually assessed at the four (2) tooth surfaces that make up each of the 12 (6 per side) qualifying interproximal test units: mesiobuccal and distobuccal (scale of 0-5, 0 =No debris or stain present on the clinical crown; 5=Plaque coverage over more than two third of the tooth surface). Change = (14 days Score - Baseline Score)	Baseline and 14 days
Change in Interproximal Plaque by Modification of the Quigley-Hein Plaque Index at 28 Days	Plaque scores shall be visually assessed at the four (2) tooth surfaces that make up each of the 12 (6 per side) qualifying interproximal test units: mesiobuccal and distobuccal (scale of 0-5, 0 =No debris or stain present on the clinical crown; 5=Plaque coverage over more than two third of the tooth surface) Change = (28 days Score - Baseline Score)	Baseline and 28 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Performance (Easy to Use) of an Assigned Product	Subjects record product performance and experience on a diary. Scale of Easy to Use was scored from 1 to 5 (1= Not easy; 5= Very easy).	28 days
Change in Gingivitis by UNC Modified Gingival Index at 28 Days	Gingiva shall be assessed at 6 sites per tooth: distobuccal, direct buccal, mesiobuccal, distolingual, direct lingual and mesiolingual surfaces (Scale is 0-3: 0 =Normal gingiva (pink, firm, stippled), 3 =Severe inflammation: marked redness and edema, ulceration, tendency to spontaneous bleeding). Change = (28 days Score - Baseline Score)	Baseline and 28 days
Change in Gingivitis by Bleeding on Probing at 28 Days	Presence or absence of bleeding within 10 seconds after probing shall be scored at 6 sites per tooth: distobuccal, distal, mesiobuccal, and distolingual, lingual and mesiolingual surfaces. The number of sites where bleeding is recorded is divided by the total number of available sites and multiplied by 100 to express the bleeding on probing as a percentage. Change = (28 days percentage - Baseline percentage)	Baseline and 28 days
Change in Gingivitis by Probing Pocket Depth at 28 Days	6 sites per tooth: distobuccal, distal, mesiobuccal, and distolingual, lingual and mesiolingual surfaces: (mm) Change = (28 days measurement - Baseline measurement)	Baseline and 28 days

Collaborators and Investigators

• Sponsor: Sunstar Americas
• Investigators: Principal Investigator: Antonio Moretti, DDS, MS, Clinical Associate Professor and Graduate Program Director

Study record dates

Study Major Dates

• Study Start: December 1, 2016
• Primary Completion (Actual): May 1, 2017
• Study Completion (Actual): May 1, 2017

Study Registration Dates

• First Submitted: August 25, 2016
• First Submitted That Met QC Criteria: August 25, 2016
• First Posted (Estimate): August 30, 2016

Study Record Updates

• Last Update Posted (Actual): December 11, 2018
• Last Update Submitted That Met QC Criteria: November 16, 2018
• Last Verified: May 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Infections; Stomatognathic Diseases; Periodontal Diseases; Mouth Diseases; Gingival Diseases; Gingivitis
• Other Study ID Numbers: CLP-2015-11-16-1

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No